Market Recap: Immuneering Corp (IMRX)’s Positive Momentum%, Closing at $8.21

Kiel Thompson

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

The closing price of Immuneering Corp (NASDAQ: IMRX) was $8.21 for the day, up 0.86% from the previous closing price of $8.14. In other words, the price has increased by $0.86 from its previous closing price. On the day, 0.93 million shares were traded. IMRX stock price reached its highest trading level at $8.45 during the session, while it also had its lowest trading level at $7.65.

Ratios:

Our analysis of IMRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.70 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 02 ’25 when HAUSMAN DIANA bought 3,000 shares for $3.62 per share. The transaction valued at 10,874 led to the insider holds 3,000 shares of the business.

HAUSMAN DIANA bought 2,500 shares of IMRX for $8,989 on Jul 02 ’25. The Director now owns 2,500 shares after completing the transaction at $3.60 per share. On Jul 02 ’25, another insider, Neufeld Leah R, who serves as the CHIEF PEOPLE OFFICER of the company, bought 700 shares for $3.57 each. As a result, the insider paid 2,499 and bolstered with 10,729 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMRX now has a Market Capitalization of 341291328 and an Enterprise Value of 273280736.

Stock Price History:

The Beta on a monthly basis for IMRX is 0.44, which has changed by 3.0643563 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, IMRX has reached a high of $9.37, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 85.47%, while the 200-Day Moving Average is calculated to be 231.23%.

Shares Statistics:

IMRX traded an average of 1.53M shares per day over the past three months and 1055480 shares per day over the past ten days. A total of 35.99M shares are outstanding, with a floating share count of 26.05M. Insiders hold about 28.28% of the company’s shares, while institutions hold 10.54% stake in the company. Shares short for IMRX as of 1756425600 were 1830280 with a Short Ratio of 1.19, compared to 1753920000 on 1555893. Therefore, it implies a Short% of Shares Outstanding of 1830280 and a Short% of Float of 5.3600002.

Earnings Estimates

Immuneering Corp (IMRX) is currently under the scrutiny of 4.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.21 and low estimates of -$0.78.

Analysts are recommending an EPS of between -$1.29 and -$2.25 for the fiscal current year, implying an average EPS of -$1.59. EPS for the following year is -$1.5, with 4.0 analysts recommending between -$0.74 and -$1.98.

Leave a Comment

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.